
Patients with cystic fibrosis may benefit from a 1000 mg vitamin C supplement, which can increase the bioavailability of other antioxidants.
Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Patients with cystic fibrosis may benefit from a 1000 mg vitamin C supplement, which can increase the bioavailability of other antioxidants.
Subgroup analyses suggest that a primary dose of the COVID-19 vaccine does not increase risk of herpes zoster infection, regardless of age, immunocompromised status, and type of vaccine administered.
Australia also experienced their highest flu season in 5 years, which may foreshadow a bad flu season in the Northern Hemisphere.
Our Best Shot (OBS) is a new children’s book explaining why we should get an annual flu shot and it is not something to fear…and adults may even benefit, said the author.
Approximately 2 years after patients were infected with COVID-19, non-hospitalized patients suffered from post-COVID-19 symptoms nearly 8% more than hospitalized patients.
Mild preeclampsia and late-developing preeclampsia were not found to increase risk of stroke as much as early-stage.
Changes in DNA methylation may lead to accelerated aging in patients with cancer and HIV.
Sugar…may not always be sweet. Survivors of childhood cancer have a risk of accelerated aging with every 25 grams of sugar consumed, according to researchers.
There is at least a 28% difference in the amount of licensed US substance use disorder facilities that accept Medicaid and private insurance compared to Medicare, according to new research.
Like using good nutrients to grow tomatoes in the soil, good nutrients and diverse microbes are important for our good gut health, or our gut's "garden," said a leading researcher.
Mirvetuximab soravtansine-gynx (Elahere; ImmunoGen Inc) approved FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
When it comes to individualized treatment, “we can do better,” said John Edwards, vice president of Healthcare Solutions Consulting at SoftServe.
Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.
States with a higher prevalence of Medicaid patients with type 2 diabetes were found to have lower use ratio of glucose-lowering agents with known cardiovascular benefits.
A new study suggests that 30.5% of US adults lose out on 1 hour or more of sleep due to disturbances.
The book aims to make the vaccination process less scary and allow more children to be vaccinated.
Controlling blood pressure may be the most important type of treatment for vasculitis and lupus patients, said a professor of renal medicine at ASN Kidney Week in Orlando, Florida.
Daprodustat is suggested to improve anemia and quality-of-life in patients with chronic kidney disease.
Active patient care with chronic kidney disease may provide enormous benefits for patients, the economy, and society.
Next-generation research shows that targeting specific Kir channels, which regulate salt reabsorption in the kidneys, could improve diuretic function in kidney patients.
Healthcare practitioner finds that institutions need to acknowledge advantaged and disadvantaged groups of patients as motivation to overcome systemic barriers.
Pharmacists should get out from behind the glass from time to time and work with chronic kidney disease patients to better understand their medications and lifestyle decisions, said an analyst who spoke at ASN Kidney Week in Orlando, Florida.
Researchers outline new findings about the connection between hyperkalemia and renin-angiotensin-aldosterone system inhibitors during a session at ASN Kidney Week.
Applying the principles of precision medicine to peritoneal dialysis could improve the flexibility and personalization of care for dialysis patients.
Promising data suggest triplet regimens may more effectively treat patients with unresected and metastatic intrahepatic cholangiocarcinoma.
Education, awareness, and more training may help more pharmacists and kidney patients consider home dialysis as an effective treatment option, said an expert on November 4 at ASN Kidney Week in Orlando, Florida.
Among heart failure patients, those who were at risk of social isolation had a worse attitude about advance care planning.
Researcher suggests that medications for high blood pressure may be useful in treating patients with slow-onset immunoglobulin A nephropathy, a topic he will present on this weekend at ASN Kidney Week in Orlando, Florida.
Daniel Weiner, MD, MS, associate professor at Tufts University, discusses effective treatment approaches for diabetic kidney disease at ASN Kidney Week.
It may be worth considering the pathophysiology and vascular complications of chemotherapy, especially among patients who are already hypertensive.